Ledger.Open graph →

SEC Form D · filed July 7, 2023

NeuBase Therapeutics, Inc

Offering

$5.0M

Sold

$5.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

PITTSBURGH, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Franklyn Prendergast · Aliso Viejo, CADirector Dov Goldstein · San Francisco, CADirector Eric Richman · SEATTLE, WADirector Todd Branning · Pittsburgh, PAExec Dietrich Stephan · Edgewater, NJExec · Director Gerald Mcdougall · Pittsburgh, PADirector Eric Richman · SEATTLE, WADirector Todd Branning · Pittsburgh, PAExec Dietrich Stephan · EAST LIVERPOOL, OHExec · Director Franklyn Prendergast · Aliso Viejo, CADirector Gerald Mcdougall · Pittsburgh, PADirector Dov Goldstein · New Yotk, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗